| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a47d1bb812f0b7945aa5a9d9f38f62c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14de0506e71d6d9182cf53feb9858931
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_780f48ee1930b5a17c57f7ffbe9eaddb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-02 |
| filingDate |
2006-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_690c6a58a2c085208d8c2a99a1da02a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a0f5dfa236b23677e8c5579c0d03cfe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4e2b2b9371adec7db137a69ae54858b |
| publicationDate |
2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008063157-A3 |
| titleOfInvention |
A nanoparticle-based anticoagulant |
| abstract |
A method for preventing or treating a blood clotting disorder is disclosed. The method includes administering a therapeutic effective amount of at least one nanoparticle-based anticoagulant to a subject afflicted with blood clotting disorder or potentially afflicted with a blood clotting disorder, wherein the at least one nanoparticle-based anticoagulant is a substituted fullerene, polyamidoamine (PAMAM) dendrimer or combination thereof. |
| priorityDate |
2006-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |